Insider · CIK 0001810929
Hannah Mamuszka
Files at BNGO (Bionano Genomics, Inc.). First filing -, latest -.
Hannah Mamuszka files SEC Form 4 as director at BNGO (Bionano Genomics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Hannah Mamuszka has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2025 | BNGO Bionano Genomics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +2,775 | $0.00 | $0 | 2,775 | Jun 12, 2025 |
Questions about Hannah Mamuszka
Answered from the filings on this page, as of the latest one.
Is Hannah Mamuszka buying or selling?
Hannah Mamuszka has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Hannah Mamuszka's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Hannah Mamuszka has 0.
Where does Hannah Mamuszka file Form 4?
Hannah Mamuszka has filed Form 4 at BNGO (Bionano Genomics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.